Quality of life (Qol) with capecitabine in patients with metastatic colorectal cancer (MCRC)
C. A. M Beato B Van Eyll; M. H Federico; M. R Perdicaris; N Skare; S Cabral; E Saltz; F Franke; G. L Moura; F. U Paula; ECCO 13: The European Cancer Conference 2005 Paris 13
European Journal of Cancer Oxford v. 3, n. 2, supl., p. 365, res. 1268
Effecst of capecitabine (X) on quality of life (Qol) in patients (pts) with metastatic coloretal cancer (MCRC)
C. A. M. Beato Miriam Hatsue Honda Federico; B. Van Eyll; S Cabral; M Perdicaris; N. G Skare; S Lago; M. P Carvalho; G. L Moura; R. C Duarte; Annual Meeting Proccedings (40. 2004 New Orleans)
Journal of Clinical Oncology Philadelphia v. 22, n. 14S, res. 8119, 2004
Philadelphia 2004
Localização:
FM - Fac. Medicina
(BCSEP 2004 087 ) e outros locais(Acessar)
Evaluation of quality of life (QoL) in patients (pts) with metastatic colorectal cancer (MCRC) treated with capecitabine (X)
J Segalla B. van Eyll; M Federico; M Perdicaris; S Cabral; N Skare; E saltz; G Moura; U Filho; F Franke; Annual Meeting of the American Society of Clinical Oncology 2010 Orlando) (41
Journal of Clinical Oncology Philadelphia v. 23, n. 16S , p. 751s, res. 8090, 2005